We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02041351
Recruitment Status : Completed
First Posted : January 22, 2014
Last Update Posted : January 27, 2016
Information provided by (Responsible Party):
Jesus Livio Jimenez Santos, Centro Universitario contra el Cáncer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2014
  Study Completion Date : December 2015